George Beschen serves as the Senior Director of Individual Giving at Fox Chase Cancer Center, where he leverages over 25 years of experience in communications and fundraising to drive impactful philanthropic initiatives. In his pivotal role, George collaborates closely with leaders across the Head and...
George Beschen serves as the Senior Director of Individual Giving at Fox Chase Cancer Center, where he leverages over 25 years of experience in communications and fundraising to drive impactful philanthropic initiatives. In his pivotal role, George collaborates closely with leaders across the Head and Neck Cancer and Melanoma clinical programs, ensuring that fundraising strategies align seamlessly with the center's institutional priorities. His expertise in prospect research and strategic communications allows him to effectively translate complex medical advancements into compelling narratives that resonate with potential donors.
George is instrumental in producing and overseeing major stewardship and recognition projects, which not only acknowledge donor contributions but also foster long-term relationships with supporters. His ability to cultivate donor engagement is evident in the successful execution of high-profile donor cultivation events that highlight the groundbreaking research and clinical care at Fox Chase. By employing his skills in annual giving, planned giving, and philanthropy, he has significantly enhanced the center's fundraising efforts, ensuring that vital resources are directed toward innovative cancer research and patient care.
In addition to his fundraising acumen, George is a skilled public speaker and communicator, adept at crafting messages that inspire and mobilize support from various stakeholders. His commitment to collaboration and strategic thinking has positioned him as a key player in advancing the mission of Fox Chase Cancer Center, making a meaningful impact in the fight against cancer. Through his leadership, George continues to elevate the center's visibility and philanthropic potential, ultimately contributing to the advancement of cancer treatment and research.
